Actavis
Valeant looking to buy Zoetis
June 26, 2015Sales and Marketing Actavis, Allergan, Valeant, Zoetis, brett wells
Canadian drugmaker Valeant Pharmaceuticals has made a move to acquire animal health company Zoetis. This is according to the Wall …
UK Court weighs in on Lilly-Actavis Alimta case
June 26, 2015Medical Communications, Sales and Marketing Actavis, Alimta, UK, lilly
Actavis will be infringing Lilly’s patent if it were to produce generic versions of Alimta, the UK Court of Appeal …
Actavis changes its name to Allergan
June 16, 2015Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Valeant
Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …
Actavis and Valeant see FDA approval for IBS drugs
May 28, 2015Sales and Marketing Actavis, FDA, IBS, Valeant, brett wells
Both Actavis and Valeant have been shown the green light for their respective irritable bowel syndrome (IBS) treatments from the …
Actavis confirms retirement of its comms officer
April 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, charles mayr
Ireland-based pharma firm Actavis has announced its chief communications officer Charles Mayr (pictured) is to retire shortly due to health …
Actavis gains new Allergan directors
March 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Michael Gallagher, Peter McDonnell
Ireland, Dublin-based pharma firm Actavis has added former Allergan members Michael Gallagher and Dr Peter McDonnell to its board of …
Valeant sprints ahead of Endo to secure Salix
March 18, 2015Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix
Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …
German court rules against Lilly in Alimta patent case
March 10, 2015Manufacturing and Production, Sales and Marketing ACS, Actavis, Alimta, NICE, NSCLC, lilly, lung cancer, pemetrexed
A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …
AstraZeneca completes respiratory deal with Actavis
March 3, 2015Research and Development, Sales and Marketing Actavis, AstraZeneca, COPD, Daliresp, Tudorza Pressair, aclidinium bromide inhalation powder, respiratory, roflumilast
AstraZeneca has completed its acquisition of Dublin-headquartered firm Actavis with its branded respiratory portfolio deal worth $700 million. The agreement …
Actavis and AZ see FDA approval for ‘superbug’ drug
February 27, 2015Research and Development, Sales and Marketing Actavis, AstraZeneca, Avycaz, FDA, US, ceftazidime/avibactam
Actavis and AstraZeneca’s combo ‘superbug’ drug Avycaz has been shown the green light to treat patients with complicated intra-abdominal infections …
AstraZeneca looks for revenue boost via Actavis buy
February 6, 2015Sales and Marketing Actavis, AstraZeneca, Brilinta, Forxiga, diabetes, fourth quarter, q4
AstraZeneca recorded a dip in revenue in the last quarter of 2014 and is looking to ramp up its respiratory …
Actavis buys generics firm for £306 million
January 26, 2015Manufacturing and Production, Sales and Marketing Actavis, Allergan, Auden McKenzie, generics
Actavis is buying UK-based development and marketing firm Auden McKenzie in a deal worth up to £306 million. The move …
Valeant recalls drug used on hospitalised infants
January 6, 2015Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole
North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …
Actavis hires senior head from PwC
December 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC
Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer. Reporting …
Actavis to axe 200 jobs
December 4, 2014Medical Communications, Sales and Marketing Actavis, Allergan, Forest, GSK, Warner Chilcott, corona, stevenage
Actavis is set to cut 200 jobs in the US just weeks after buying Allergan for $66 billion. The lay-offs …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
